• 1. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
• 2. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 3. Excited-state proton-coupled electron transfer within ion pairs?
  Gerald J. Meyer,Leif Hammarstr?m Chem. Sci., 2020,11, 3460-3473
• 4. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 5. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789

Introduction to 3-bromo-5-(2-methyl-2-propanyl)aniline (CAS No. 156264-80-1)

3-bromo-5-(2-methyl-2-propanyl)aniline, a compound with the chemical identifier CAS No. 156264-80-1, is a significant molecule in the field of pharmaceutical and chemical research. This compound belongs to the class of aromatic amines, characterized by its bromine substituent and an isobutyl group attached to the aniline core. The unique structural features of this molecule make it a valuable intermediate in the synthesis of various pharmacologically active agents.

The synthesis and application of 3-bromo-5-(2-methyl-2-propanyl)aniline have garnered considerable attention due to its role in developing novel therapeutic agents. The presence of both bromine and isobutyl groups provides multiple sites for further functionalization, enabling chemists to tailor the molecule for specific biological activities. Recent advancements in synthetic methodologies have enhanced the efficiency and scalability of producing this compound, making it more accessible for industrial applications.

In the realm of medicinal chemistry, 3-bromo-5-(2-methyl-2-propanyl)aniline has been explored as a precursor in the design of small-molecule inhibitors targeting various disease pathways. For instance, studies have demonstrated its utility in generating compounds with potential antitumor and anti-inflammatory properties. The bromine atom on the aromatic ring serves as a handle for cross-coupling reactions, such as Suzuki-Miyaura and Buchwald-Hartwig couplings, which are pivotal in constructing complex molecular architectures.

One of the most compelling aspects of 3-bromo-5-(2-methyl-2-propanyl)aniline is its versatility in drug discovery. Researchers have leveraged its structural framework to develop molecules that interact with specific biological targets. For example, derivatives of this compound have shown promise in modulating enzyme activity and receptor binding affinity. The isobutyl group not only enhances solubility but also influences metabolic stability, making it an attractive feature for pharmacokinetic optimization.

The growing interest in 3-bromo-5-(2-methyl-2-propanyl)aniline is also reflected in the increasing number of patents and publications detailing its synthetic routes and biological evaluations. Companies specializing in fine chemicals have incorporated this compound into their catalogues, recognizing its potential as a building block for innovative drug candidates. The demand for high-purity 3-bromo-5-(2-methyl-2-propanyl)aniline has led to improvements in manufacturing processes, ensuring consistent quality for research and development purposes.

Recent research has also highlighted the role of 3-bromo-5-(2-methyl-2-propanyl)aniline in developing next-generation therapeutics. For instance, studies have investigated its incorporation into peptidomimetics designed to mimic natural bioactive peptides. The bromine substituent facilitates modifications that enhance binding interactions with biological targets, while the isobutyl group contributes to improved pharmacokinetic profiles. These findings underscore the compound's importance as a versatile tool in medicinal chemistry.

The future prospects of 3-bromo-5-(2-methyl-2-propanyl)aniline are promising, with ongoing research exploring new synthetic strategies and applications. Advances in computational chemistry and artificial intelligence are expected to further accelerate the discovery process by predicting novel derivatives with enhanced biological activity. As our understanding of disease mechanisms evolves, compounds like 3-bromo-5-(2-methyl-2-propanyl)aniline will continue to play a crucial role in addressing unmet medical needs.

In conclusion, 3-bromo-5-(2-methyl-2-propanyl)aniline (CAS No. 156264-80-1) is a multifaceted compound with significant implications for pharmaceutical research and development. Its unique structural features and synthetic versatility make it an indispensable tool for chemists and biologists striving to develop innovative treatments for various diseases. As scientific knowledge progresses, the applications of this compound are likely to expand, reinforcing its importance in modern drug discovery efforts.

• 51605-97-1(2-Bromo-4-isopropylaniline)
• 103273-01-4(2-bromo-4-tert-butyl-aniline)
• 63818-33-7(3-Bromo-4-(tert-butyl)aniline hydrochloride)
• 123158-68-9(3-Bromo-5-ethylaniline)
• 103275-21-4(3-Bromo-4-(tert-butyl)aniline)
• 80058-84-0(4-bromo-2,6-bis(propan-2-yl)aniline)
• 10546-65-3(2,6-Dibromo-4-isopropylaniline)
• 10546-67-5(2,6-Dibromo-4-tert-butylaniline)
• 58164-14-0(2-Bromo-5-(tert-butyl)aniline)
• 74586-53-1(3-Bromo-5-methylaniline)